Vitamin D supplementation in the prevention of Neonatal Bronchopulmonary Dysplasia: is it beneficial?

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210622001

Enrollment

100

Registered

2021-06-22

Start date

2016-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Bronchopulmonary Dysplasia Neonate, vitamin D, bronchopulmonary dysplasia

Interventions

Group 1: who received single daily enteral 8 drops of vitamin D (800 IU) for 2 weeks ,placebo is 2ml of distilled water

Experimental Dietary Supplement,Experimental Other

vitamin D supplementation,placebo group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: neonates suffering from respiratory distress

Exclusion criteria

Exclusion criteria: neonatal infections

Design outcomes

Primary

Measure	Time frame
bronchopulmonary dysplasia 1 and 14 days ELISA	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Egypt

Contacts

Public ContactMohamed Elfarargy

Tanta University Hospital

farargy2009@hotmail.com00201005171750

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026